Provided by Tiger Trade Technology Pte. Ltd.

Fractional Shares

1,995.13
-14.6964-0.73%
Number of Gainers:250
Number of Losers:752
Number of Flat:19
PE:- -
High:2,010.08
Open:2,010.08
Low:1,989.67
Close:2,009.83
Volume:5.26B
Turnover:658.93B
Market Cap:95.43T
Float Cap:89.37T

Loading ...

Hormel Foods Q3 Operating Income USD 111 Million VS. Ibes Estimate USD 263 Million

THOMSON REUTERS
·
Aug 27

Hormel Foods: Expects Net Sales to be in the Range of $12.1 Billion to $12.2 Billion for Fiscal 2026

THOMSON REUTERS
·
Aug 27

Beyond the Cycle: How Zhihu Is Evolving Into an AI Data Infrastructure and IP Powerhouse

Stock News
·
Aug 27

Equinor Board Member Finn Bjørn Ruyter to Step Down from Sept. 1, 2026

Reuters
·
Aug 27

Ducommun CEO Oswald to Join B. Riley Consumer & TMT Conference Investor Meetings

Reuters
·
Aug 27

Canadian Solar: Expect Margins in Q3 to Remain Stable

THOMSON REUTERS
·
Aug 27

Canadian Solar Q2 EPS USD -1.4

THOMSON REUTERS
·
Aug 27

Canadian Solar: Q3 Outlook Total Revenue $1.3 Bln-$1.5 Bln

THOMSON REUTERS
·
Aug 27

Canadian Solar: in Q3, Module Shipments Recognized as Revenue Expected to be in Range of 3.5 Gw to 3.8 Gw

THOMSON REUTERS
·
Aug 27

Canadian Solar: Reiterating Guidance of Solar Modules & Battery Energy Storage Solutions for U.S. Market in 2026

THOMSON REUTERS
·
Aug 27

Canadian Solar Q2 Revenue USD 1,200 Million VS. Ibes Estimate USD 1,140 Million

THOMSON REUTERS
·
Aug 27

Canadian Solar Inc Q3 REV View $1.81 Bln

THOMSON REUTERS
·
Aug 27

Canadian Solar Q2 Gross Margin 13.9%

THOMSON REUTERS
·
Aug 27

Bilibili Inc. Announces Second Quarter 2026 Financial Results

THOMSON REUTERS
·
Aug 27

China's Bilibili Q2 Net Profit Jumps 55% on Ad Growth

Reuters
·
Aug 27

Bilibili Inc. Q2 Basic EPS RMB 0.82

THOMSON REUTERS
·
Aug 27

Bilibili Inc. Q2 Pretax Profit RMB 371.493 Million

THOMSON REUTERS
·
Aug 27

ROI-Monetarist Resurrection, or Timely Rethink of Inflation Targeting?: Mike Dolan

Reuters
·
Aug 27

Lotus Technology Reports Unaudited Half Year 2026 Financial Results

GlobeNewswire
·
Aug 27

JW Cayman Therapeutics FY26 H1 IFRS Loss Narrows 81.14% to RMB 50.4 Million; Revenue Rises 4.7% to RMB 111.4 Million

Reuters
·
Aug 27